Arno Therapeutics, Inc. HomeAbout UsPipelineInvestor RelationsContact Us
Creating the next generation of cancer treatments
Investor & Media
Press ReleasesIn the NewsPublicationsEvents & PresentationsStock Information
SEC FilingsAnnual ReportsGovernanceTransfer Agent

PRESS RELEASES



January 8, 2015

Arno Therapeutics to Present at 11th Annual Noble Equity

FLEMINGTON, NJ - January 8, 2015 - Arno Therapeutics, Inc. (OTCQB: ARNI), a clinical stage biopharmaceutical company primarily focused on the development of oncology therapeutics, today announced that Chief Operating Officer, Lawrence Kenyon, is scheduled to present at the Noble Financial Capital Markets' 11th Annual Equity Conference, being held January 18-21, 2015 at Club Med in Sandpiper Bay, FL.

Mr. Kenyon will present on Tuesday, January 20 at 4:00 p.m. EST to attending investors. During his presentation, Mr. Kenyon will discuss Arno's ongoing clinical development of lead candidate and personalized oncology therapy, onapristone, and recent milestones, including the first patient enrolled in the Phase II component of the Company's modified Phase I/II clinical study evaluating onapristone in women with progesterone receptor expressing tumors.

Details of the presentation are as follows:

Date: Tuesday, January 20, 2015
Time: 4:00 p.m. EST
Location: Club Med in Sandpiper Bay, Florida
Room: Room 1

At the time of the Noble presentation, a live audio and high-definition video webcast of Arno Therapeutics presentation and a copy of the presentation materials will be available on the Company's web site www.arnothera.com, or through the Noble Financial websites: www.noblefcm.com, or www.nobleresearch.com/D2/2015.htm. Arno Therapeutics recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access. You will require a Microsoft SilverLight viewer (a free download from the presentation link) to participate. The webcast and presentation will also be archived on www.arnothera.com for 90 days following the event.

About Arno Therapeutics

Arno Therapeutics is a clinical stage biopharmaceutical company developing innovative products for the treatment of cancer and other life threatening diseases. Arno has exclusive worldwide rights to develop and market three innovative anti-cancer product candidates. These compounds are in clinical or preclinical development as product candidates to treat hematologic malignancies and solid tumors. For more information about the company, please visit www.arnothera.com.

About Noble Financial

Noble Financial Capital Markets was established in 1984. Noble Financial is an equity research driven, full-service, investment banking boutique focused on life sciences, technology, energy and media, emerging growth, companies. The company has offices in New York, Boston, Los Angeles, and Boca Raton, FL. In addition to non-deal road shows and sector-specific conferences throughout the year, Noble Financial hosts its large format annual equity conference in January in South Florida featuring 120 - 150 presenting companies from across North America and total attendance of close to 600. For more information: www.noblefcm.com




Contact:

The Ruth Group

Lee Roth (investors)
lroth@theruthgroup.com
(646) 536-7012

Kirsten Thomas (media)
kthomas@theruthgroup.com
(646) 536-7014

Arno Therapeutics
Lawrence Kenyon
lk@arnothera.com
(862) 703-7171



Arno Therapeutics, Inc.
200 Route 31 North
Suite 104
Flemington, NJ 08822

(862) 703-7170 Main
(908) 237-0071 Fax

Email